Submission Deadline: 02 February 2022 (closed)
The new viral, bacterial and fungal pathogens are currently developing resistance to several available drugs. Newly discovered drugs like compounds are more virulent to inhibiting the viral or microbial pathogens related diseases and cancer cells in vitro but is not successful in the host due to less stability and inability to targeting the pathogenic location. Therefore, discovery of the novel drugs is important and by the way development of novel strategies to enhance its therapeutic efficiency also is essential. Therefore, proper understating of the new compounds characteristics and its chemistry can enable us to develop the novel drug carrier system to improve its therapeutic efficiency. Hence, this special issue in aims to focusing the isolation of novel metabolites from the plant resources and increasing its stability and targeted delivery by using the nano-drug carrier delivery system (nDDS). Further evaluating the therapeutic efficiency of drug loaded nDDS in host level by animal experiments, including the following but not limited in scope to:
1. Bioactive compounds
2. Methods in isolation of novel compounds
3. Chromatography techniques in compounds purification
4. nDDS for improving therapeutic efficiency of natural compounds
5. Nanotechnology advances for medicinal natural product research
Open Access
ARTICLE
Open Access
ARTICLE
Open Access
ARTICLE
Open Access
ARTICLE
Open Access
ARTICLE